Zobrazeno 1 - 10
of 270
pro vyhledávání: '"R M Bertina"'
Autor:
F. R. Rosendaal, R M Bertina, S. Uitte De Willige, M. de Visser, H. L. Vos, Jeanine J. Houwing-Duistermaat
Publikováno v:
Journal of Thrombosis and Haemostasis. 6:478-485
Summary. Background: Selectins (E-, L- and P-selectin) and their most important counter-receptor P-selectin glycoprotein ligand (SELPLG) facilitate the interaction of platelets, leukocytes and endothelial cells at inflammatory sites. Selectin polymor
Autor:
F. R. Rosendaal, Anders E.A. Dahm, H. A. A. M. Van Vliet, R M Bertina, Frans M. Helmerhorst, P. Morten Sandset, Jan Rosing
Publikováno v:
Journal of Thrombosis and Haemostasis. 6:346-351
Summary. Background: Oral contraceptives (OC) containing different types of progestogens induce different sensitivities to activated protein C (APC) measured with the thrombin generation-based APC-resistance test. These differences in APC resistance
Autor:
R M Bertina, Fred P.H.T.M. Romijn, I. K. Van Der Linden, Susanne Osanto, F. A. Prins, M. E. T. Tesselaar
Publikováno v:
Journal of Thrombosis and Haemostasis. 5:520-527
Summary. Background: Cancer, in particular mucinous adenocarcinoma, is associated with venous thromboembolism (VTE). Tissue factor (TF), initiator of coagulation, plays a central role in the paradigm that clotting and tumor growth form a vicious circ
Autor:
N H van Tilburg, V. Van Marion, F. R. Rosendaal, H. C. J. Eikenboom, R M Bertina, J. A. Van Mourik, Anne Yaël Nossent
Publikováno v:
Journal of Thrombosis and Haemostasis. 4:2556-2562
Summary. Background and objectives: Elevated levels of factor (F)VIII are associated with an increased risk of thrombosis. FVIII levels are determined mainly by von Willebrand factor (VWF). We have investigated the contribution of secretion and clear
Publikováno v:
British Journal of Haematology. 124:659-665
Thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels exhibit a large interindividual variability in which genetic control seems to play a major role. However, recent reports have questioned the association between TAFI concentration and
Autor:
Frans M. Helmerhorst, E. T. M. Hille, S. Buitendijk, Mieke W. J. C. Jansen, Juriy W. Wladimiroff, C.J.M. de Groot, R M Bertina, M.P.M. de Maat, Kitty W.M. Bloemenkamp, Hans L. Vos
Publikováno v:
Journal of Thrombosis and Haemostatis, 9, 2, 1588-1593
Journal of thrombosis and haemostasis, 2(9), 1588-1593. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 2, 1588-1593. Wiley-Blackwell Publishing Ltd
Journal of thrombosis and haemostasis, 2(9), 1588-1593. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 2, 1588-1593. Wiley-Blackwell Publishing Ltd
Recently, it has been proposed that abnormalities in coagulation and fibrinolysis contribute to the development of preeclampsia by increasing the thrombotic tendency. This hypothesis was tested in women who have had preeclampsia (cases) compared with
Publikováno v:
Journal of Thrombosis and Haemostasis. 1:1771-1776
Summary. Elevated factor (F)VIII levels contribute to venous thrombotic risk. FVIII levels are determined to a large extent by levels of von Willebrand factor (VWF), its carrier protein which protects FVIII against proteolysis. VWF levels are largely
Autor:
Guido Tans, R M Bertina, Richard J. Dirven, Hans L. Vos, Jan Rosing, M. Van Der Neut Kolfschoten
Publikováno v:
Blood Coagulation & Fibrinolysis. 13:207-215
Recently, new missense mutations in the activated protein C (APC) cleavage sites of human factor V (FV) distinct from the R506Q (FV Leiden) mutation have been reported. These mutations affect the APC cleavage site at arginine (Arg) 306 in the heavy c